The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC)
point prevalence survey: developing hospital-quality indicators of antibiotic prescribingfor children.
To determine whether ongoing transmission was occurring at vSNF A, the Chicago Department of Public Health conducted 10 additional
point prevalence surveys during November 2016--March 2018.
A survey questionnaire was developed using information obtained from two of the
point prevalence studies referred to earlier.
The
point prevalence was calculated using the number of patients with the complication at the specific time point in the numerator.
Prevalence of Clostridium difficile infection in hospitalized patients with diarrhea: results of a French prospective multicenter bi-annual
point prevalence study.
[7] The European
Point Prevalence Survey of Healthcare Associated Infections and Antimicrobial Use (EU-PPS HAI&AU) in 2011 and in 2012," 2012, https://ecdc.europa.eu/sites/portal/ files/media/en/publications/Publications/healthcare-associatedinfections-antimicrobial-use-PPS.pdf.
The aims of this study were to examine the prevalence of LBP (lifetime, 12-month, and
point prevalence) among Belgrade clinical medical students, to identify self-perceived triggers of LBP, and to investigate the impact of perceived pain on their daily activities and mood.
The short-term (7-day
point prevalence) and long-term (continuous) abstinence rates in each treatment arm according to baseline characteristics are shown in Table 1.
A latest study from Pakistan has revealed high levels of anxiety (50.2%)11 whereas the average total prevalence of depression and anxiety found in public samples is 33.62%, with a
point prevalence of 45.5% amongst females and 21.7% amongst males12.
The
point prevalence of self-reported injury in professional ballet and modern dancers was 54.8% (95% CI, 47.7-62.1) and 46.3% (95% CI, 35.5-57.1), respectively.
The sample size calculation was based on expected HBsAg prevalence extrapolated from the 2006 survey by age group (0.7% for 1-4 years, 1.5% for 5-14 years, and 5.0% for 15-29 years) and was powered to detect differences of [+ or -]50% the expected
point prevalence. The final target sample size was 31,024.
A 20-year incidence trend (1989-2008) and
point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.